Pregabalin Capsule
Product Images NDC 82804-188

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 82804-188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-188-60 (Image 01)

This is a description of a medication package containing Pregabalin 150mg capsules. The package includes 60 capsules and is produced by Proficient Rx LP in Thousand Oaks, CA. The capsules are white with imprints '142' on the cap and 'J' on the body. Each capsule contains 150mg of Pregabalin. The packaging also includes information on storing the medication and a lot number for tracking purposes. This medication should be kept out of reach of children.*

FDA Label Image

Pregabalinfigure1 (Pregabalinfigure1)

FDA Label Image

Pregabalinfigure10 (Pregabalinfigure10)

FDA Label Image

Pregabalinfigure11 (Pregabalinfigure11)

FDA Label Image

Pregabalinfigure12 (Pregabalinfigure12)

FDA Label Image

Pregabalinfigure2 (Pregabalinfigure2)

FDA Label Image

Pregabalinfigure3 (Pregabalinfigure3)

FDA Label Image

Pregabalinfigure4 (Pregabalinfigure4)

This is a chart showing the percentage of patients improved with Pregabalin 200 mg three times a day, Pregabalin 100 mg three times a day, and Placebo. There is also a line graph presenting the percentage improvement in pain from baseline.*

FDA Label Image

Pregabalinfigure5 (Pregabalinfigure5)

FDA Label Image

Pregabalinfigure6 (Pregabalinfigure6)

Not available.*

FDA Label Image

Pregabalinfigure7 (Pregabalinfigure7)

FDA Label Image

Pregabalinfigure8 (Pregabalinfigure8)

This text provides information on responder rates for different dosages of a medication (2.5 mg/kg/day and 10 mg/kg/day) compared to a placebo. The responder rates are given as percentages for each dosage group.*

FDA Label Image

Pregabalinfigure9 (Pregabalinfigure9)

This text provides data on the percentage of patients who have experienced improvement in pain after being treated with different doses of Pregabalin and a placebo. The percentage of improvement is shown for doses of 600mg, 450mg, and 300mg of Pregabalin, as well as for the placebo. The chart displays the values for improvement in pain from baseline for each treatment group.*

FDA Label Image

Pregabalinstructure (Pregabalinstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.